 |
CAS PubMed Article Google Scholar
|
|
|
|
CAS PubMed Article Google Scholar
42. 42.
Ema M, Hougaard KS, Kishimoto A, Honda K. Reproductive and developmental toxicity of carbon-based nanomaterials: A literature review. Nanotoxicology. 2015; 10: 391–412.
PubMed Article CAS Google Scholar
43. 43.
Jastrzebska AM, Olszyna AR. The ecotoxicity of graphene family materials: current status, knowledge gaps and future needs. J Nanopart Res. 2015; 17(1): 1–21.
CAS Article Google Scholar
44. 44.
Xu S, Zhang Z, Chu M. Long-term toxicity of reduced graphene oxide nanosheets: Effects on female mouse reproductive ability and offspring development. Biomaterials. 2015; 54: 188–200.
CAS PubMed Article Google Scholar
45. 45.
Jennifer M, Maciej W. Nanoparticle technology as a double-edged sword: cytotoxic, genotoxic and epigenetic effects on living cells. J Biomater Nanobiotechnol. 2013; 4: 53–63.
CAS Article Google Scholar
46. 46.
Wu W, Yan L, Wu Q, Li Y, Li Q, Chen S, et al. Evaluation of the toxicity of graphene oxide exposure to the eye. Nanotoxicology. 2016; 10(9): 1329–40.
CAS PubMed Article Google Scholar
47. 47.
Lee K, Jeong Y, Bae J, Seok H, Yang Y, Roh S, et al. The role of surface functionalization on the pulmonary inflammogenicity and translocation into mediastinal lymph nodes of graphene nanoplatelets in rats. Arch Toxicol. 2016: 1–10.
48. 48.
Schinwald A, Murphy F, Askounis A, Koutsos V, Sefiane K, Donaldson K, et al. Minimal oxidation and inflammogenicity of pristine graphene with residence in the lung. Nanotoxicology. 2013; 8(8): 824–32.
PubMed Article CAS Google Scholar
49. 49.
Zhang X, Yin J, Peng C, Hu W, Zhu Z, Li W, et al. Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration. Carbon. 2011; 49(3): 986–95.
CAS Article Google Scholar
50. 50.
Singh SK, Singh MK, Nayak MK, Kumari S, Shrivastava S, Gracio JJ, et al. Thrombus inducing property of atomically thin graphene oxide sheets. ACS Nano. 2011; 5(6): 4987–96.
CAS PubMed Article Google Scholar
51. 51.
Gurunathan S, Han JW, Eppakayala V, Kim JH. Biocompatibility of microbially reduced graphene oxide in primary mouse embryonic fibroblast cells. Colloids Surf B Biointerf. 2013; 105: 58–66.
CAS Article Google Scholar
52. 52.
Yang K, Wan J, Zhang S, Zhang Y, Lee ST, Liu Z. In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. ACS Nano. 2011; 5(1): 516–22.
CAS PubMed Article Google Scholar
53. 53.
Fu C, Liu T, Li L, Liu H, Liang Q, Meng X. Effects of graphene oxide on the development of offspring mice in lactation period. Biomaterials. 2015; 40: 23–31.
PubMed Article CAS Google Scholar
54. 54.
Hu Q, Jiao B, Shi X, Valle RP, Zuo YY, Hu G. Effects of graphene oxide nanosheets on the ultrastructure and biophysical properties of the pulmonary surfactant film. Nanoscale. 2015; 7(43): 18025–9.
|
|
|
CAS PubMed PubMed Central Article Google Scholar
55. 55.
Gosens I, Post JA, de la Fonteyne LJ, Jansen EH, Geus JW, Cassee FR, et al. Impact of agglomeration state of nano- and submicron sized gold particles on pulmonary inflammation. Part Fibre Toxicol. 2010; 7(1743–8977 (Electronic)): 1.
Google Scholar
56. 56.
Geiser M, Kreyling WG. Deposition and biokinetics of inhaled nanoparticles. Part Fibre Toxicol. 2010; 7: 2.
PubMed PubMed Central Article CAS Google Scholar
57. 57.
Ruge CA, Schaefer UF, Herrmann J, Kirch J, Canadas O, Echaide M, et al. The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles. PLoS One. 2012; 7(7): e40775.
CAS PubMed PubMed Central Article Google Scholar
58. 58.
Morfeld P, Treumann S, Ma-Hock L, Bruch J, Landsiedel R. Deposition behavior of inhaled nanostructured TiO2 in rats: fractions of particle diameter below 100 nm (nanoscale) and the slicing bias of transmission electron microscopy. Inhal Toxicol. 2012; 24(1091–7691 (Electronic)): 939–51.
CAS PubMed Article Google Scholar
59. 59.
Wiemann M, Vennemann A, Sauer UG, Wiench K, Ma-Hock L, Landsiedel R. An in vitro alveolar macrophage assay for predicting the short-term inhalation toxicity of nanomaterials. J Nanobiotechnol. 2016; 14(1477–3155 (Electronic)): 1.
Google Scholar
60. 60.
Kreyling WG, Semmler-Behnke M, Takenaka S, Mö ller W. Differences in the biokinetics of inhaled nano- versus micrometer-sized particles. Accounts Chem Res. 2012; 46(1520–4898 (Electronic)): 714–22.
Google Scholar
61. 61.
Liang M, Hu M, Pan B, Xie Y, Petersen EJ. Biodistribution and toxicity of radio-labeled few layer graphene in mice after intratracheal instillation. Part Fibre Toxicol. 2016; 13(1): 1–12.
Google Scholar
62. 62.
Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood–brain barrier. Neurobiol Dis. 2010; 37(1): 13–25.
CAS PubMed Article Google Scholar
63. 63.
Mendonca MC, Soares ES, de Jesus MB, Ceragioli HJ, Ferreira MS, Catharino RR, et al. Reduced graphene oxide induces transient blood–brain barrier opening: an in vivo study. J Nanobiotechnol. 2015; 13: 78.
Article Google Scholar
64. 64.
Liu Y, Xu LP, Dai W, Dong H, Wen Y, Zhang X. Graphene quantum dots for the inhibition of beta amyloid aggregation. Nanoscale. 2015; 7(45): 19060–5.
CAS PubMed Article Google Scholar
65. 65.
Mital P, Hinton BT, Dufour JM. The blood-testis and blood-epididymis barriers are more than just their tight junctions. Biol Reprod. 2011; 84(5): 851–8.
CAS PubMed PubMed Central Article Google Scholar
66. 66.
Liang S, Xu S, Zhang D, He J, Chu M. Reproductive toxicity of nanoscale graphene oxide in male mice. Nanotoxicology. 2015; 9(1): 92–105.
|
|
|
